LifeMD News

LifeMD Inc from time to time submits prospectus relating to the resale and sale of up to 1.3 million common shares held by shareholders — US Securities and Exchange Commission filing

LifeMD Inc from time to time submits prospectus relating to the resale and sale of up to 1.3 million common shares held by shareholders — US Securities and Exchange Commission filing

Zhitong FinanceMay 31 13:16

Express News | LifeMD Inc Files Prospectus Related to Resale, From Time to Time, of up to 1.3 Mln Shares of Common Stock Held by Selling Stockholders -SEC Filing

BreakingsMay 31 13:15

Is It Too Late To Consider Buying LifeMD, Inc. (NASDAQ:LFMD)?

Yahoo FinanceMay 31 05:17

Russell 3000: Veru, Life MD Among Consumer Staple Additions; Benson Hill, PetMed Express Among Deletions

Seeking AlphaMay 30 16:29

LifeMD Shares Are Trading Higher After It Was Announced the Stock Will Be Added to the Russell 3000 Index.

LifeMD Shares Are Trading Higher After It Was Announced the Stock Will Be Added to the Russell 3000 Index.

BenzingaMay 30 14:25

LifeMD (LFMD) Gets a Buy From Craig-Hallum

TipRanksMay 30 08:07

LifeMD Set to Join the Russell 3000 Index

Yahoo FinanceMay 29 07:00

URBN, SHLS and VSAT Are Among After Hour Movers

Seeking AlphaMay 21 16:03

LifeMD Price Target Maintained With a $12.00/Share by B. Riley Securities

LifeMD Price Target Maintained With a $12.00/Share by B. Riley Securities

Dow JonesMay 21 10:55

B. Riley Securities: Reiterated LifeMD (LFMD.US) rating and adjusted from buy to buy rating, target price of $12.00.

B. Riley Securities: Reiterated LifeMD (LFMD.US) rating and adjusted from buy to buy rating, target price of $12.00.

Zhitong FinanceMay 21 10:50

B. Riley Securities Reiterates Buy on LifeMD, Maintains $12 Price Target

B. Riley Securities analyst William Woods reiterates LifeMD with a Buy and maintains $12 price target.

Analyst UpgradesMay 21 10:45

Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD) and Dyne Therapeutics (DYN)

TipRanksMay 20 11:20

Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting Its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications

GLP-1 Lifestyle Program brings together clinician-prescribed medications, coach support and new GLP-1 Nutrition Support Kit designed for medication users National advertising campaign with planned $30 million

BusinesswireMay 20 07:00

LifeMD (LFMD) Receives a Buy From Craig-Hallum

TipRanksMay 16 08:06

LifeMD First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceMay 10 08:02

HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $12 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $12 price target.

BenzingaMay 10 07:42

Buy Rating Affirmed for LifeMD on Strong Q1 Revenue Growth and Upbeat 2024 Outlook

TipRanksMay 10 05:45

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results.Duolingo reported quarterly earnings of 57 cents per share whic

BenzingaMay 9 12:57

LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 10:46

Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating

LifeMD (LFMD) has an average rating of buy and price targets ranging from $11 to $16, according to analysts polled by Capital IQ. Price: 9.45, Change: -2.88, Percent Change: -23.39

MT NewswiresMay 9 10:21